Ampersand Capital Partners

Ampersand Capital Partners is a Boston-based private equity firm specializing in growth-oriented investments in the healthcare sector. With over 35 years of experience, they focus exclusively on lower middle market healthcare companies, typically with revenues between $10 and $200 million. Their expertise lies in several key healthcare sectors, including laboratory testing services, laboratory products, contract manufacturing, pharma services, and specialty pharma. Ampersand has a strong track record of partnering with entrepreneurs to help them build market-leading companies, driven by their unique blend of private equity and operating expertise.

Ampersand has a reputation for being a "founder-friendly" investor, building supportive working relationships with their management teams. They believe in teamwork and consensus decision-making, with every investment being endorsed by the entire Ampersand team. Their commitment to "straight talk" and "constructive impatience" fosters a culture of open communication and action-oriented problem-solving, contributing to the success of their portfolio companies.

Ampersand Capital Partners is a Boston-based private equity firm dedicated to growth-oriented investments in the healthcare sector. With over 25 years of experience, Ampersand leverages its industry expertise and global presence to partner with entrepreneurs in building market-leading healthcare companies. They focus on lower middle-market businesses within key sectors like laboratory products, services, contract manufacturing, pharma services, and specialty pharma, typically investing between $10 and $200 million of equity to accelerate growth and drive long-term performance alongside their portfolio company management teams.

Ampersand Capital Partners prioritizes a collaborative and transparent culture, characterized by teamwork, consensus decision-making, and straight talk. They value respect for entrepreneurs, emphasizing a supportive working relationship with management teams, and encourage constructive impatience, promoting a bias towards action and new ideas.